Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preclinical antitumor activity of FK-228

Dec. 2, 2002

Phase I findings for AP-5280 support initiation of phase I/II trial

Nov. 29, 2002

Potential new kinase inhibitors for potentiating the effects or radio- and/or chemotherapy

Nov. 29, 2002

NDA for palonosetron accepted for filing by the FDA

Nov. 28, 2002

New nonanticoagulant heparin derivatives retain antiangiogenic/antitumor activity

Nov. 28, 2002

Gemin X's Bcl-2 inhibitors are effective proapoptotic and antitumor compounds

Nov. 28, 2002

Cotara receives orphan drug status in E.U.

Nov. 27, 2002

New series of HDAC inhibitors prepared and tested by Roche researchers

Nov. 27, 2002

Allergan licenses rights to PEP-005 from Peplin Biotech

Nov. 27, 2002

Vertex presents novel inhibitors of caspase and TNF-alpha production

Nov. 27, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...